Skip to content
HowShorted

Moleculin Biotech, Inc. short interest in 2023

In 2023, Moleculin Biotech, Inc.'s disclosed short interest ran from 0.27% of shares outstanding on 13 Jan 2023 to 1.06% on 29 Dec 2023, a change of +0.79 percentage points. The year's high was 1.14% on 15 Dec 2023 and its low 0.03% on 31 May 2023, averaging 0.39% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.75 days on 15 Dec 2023. Full history: Moleculin Biotech, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2025

Aggregate net short position time series for Moleculin Biotech, Inc. in 2023

2023 in figures

Start of year
0.27% (13 Jan 2023)
End of year
1.06% (29 Dec 2023)
Change
+0.79 pp
High
1.14% (15 Dec 2023)
Low
0.03% (31 May 2023)
Average
0.39%
Highest days to cover
2.75 (15 Dec 2023)
SEC filings marked
8

Every report in 2023

Moleculin Biotech, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20230.27%1.33
31 Jan 20230.14%1.00
15 Feb 20230.22%1.00
28 Feb 20230.15%1.57
15 Mar 20230.13%1.00
31 Mar 20230.10%1.0010-K filed, results (8-K)
14 Apr 20230.08%1.00
28 Apr 20230.06%1.00
15 May 20230.07%1.0010-Q filed, results (8-K)
31 May 20230.03%1.00
15 Jun 20230.06%1.00
15 Aug 20230.52%2.6910-Q filed, results (8-K)
29 Sep 20230.60%1.97
13 Oct 20230.27%1.02
31 Oct 20230.62%1.00
15 Nov 20231.00%1.4510-Q filed, results (8-K)
30 Nov 20230.85%2.71
15 Dec 20231.14%2.75
29 Dec 20231.06%1.17

See also: Moleculin Biotech, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.